Khosla Rachna
SEC CIK 1881332 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | SVP, Business Development | 6,404 | — | $2.19M | 40 | 2021-11-05 | 2026-08-13 |
Most active insiders at AMGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Santos Esteban | EVP, Ops | — | $20.77M |
| 2 | Grygiel Nancy A. | SVP, CCO | — | $2.65M |
| 3 | Gordon Murdo | EVP, Gbl Commercial Ops | — | $2.32M |
| 4 | Khosla Rachna | SVP, Business Development | — | $1.65M |
| 5 | Miller Derek | SVP, Human Resources | — | $1.57M |
| 6 | Busch Matthew C. | VP, CAO, Fin | — | $375.8K |
| 7 | Klotman Mary E. | Dir | — | — |
| 8 | Bradner James E. | EVP, Research, Development | — | — |
| 9 | Drake Michael V | Dir | — | — |
| 10 | Griffith Peter H. | EVP, CFO | — | — |
Transactions 40
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-13 19:05 | 2026-08-11+ | AMGN | Amgen | Khosla Rachna | SVP, Business Development | S - Sale+OE | $414.05 | -3,252 | 6,404 | -34% | -$1.35M |
| D | 2026-08-13 19:05 | 2026-08-13 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | M - OptEx | $162.60 | +1,252 | 7,656 | +20% | +$203.6K |
| 2026-05-11 20:04 | 2026-05-07 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $331.11 | -93 | 8,394 | -1% | -$30.8K | |
| D | 2026-05-07 20:52 | 2026-05-05 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | A - Grant | $0.00 | +500 | 8,566 | +6% | $0 |
| D | 2026-05-07 20:52 | 2026-05-06 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $329.59 | -79 | 8,487 | -0.9% | -$26.0K |
| M | 2026-05-05 20:11 | 2026-05-02 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $329.82 | -225 | 8,066 | -3% | -$74.2K |
| 2026-03-18 | 2026-03-16 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $366.21 | -707 | 8,291 | -8% | -$258.9K | |
| 2026-03-05 | 2026-03-03 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | A - Grant | $0.00 | +1,876 | 8,972 | +26% | $0 | |
| 2025-11-13 | 2025-11-12 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | S - Sale | $336.24 | -890 | 7,082 | -11% | -$299.3K | |
| 2025-11-07 | 2025-11-05 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $296.70 | -226 | 7,972 | -3% | -$67.1K | |
| 2025-06-06 | 2025-06-05 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | S - Sale | $289.68 | -1,500 | 8,162 | -16% | -$434.5K | |
| D | 2025-05-08 | 2025-05-06 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | A - Grant | $0.00 | +610 | 9,662 | +7% | $0 |
| M | 2025-05-06 | 2025-05-02 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $283.78 | -214 | 9,156 | -2% | -$60.7K |
| 2025-05-02 | 2025-04-30 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $288.56 | -74 | 9,266 | -0.8% | -$21.4K | |
| 2025-03-19 | 2025-03-17 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $313.71 | -489 | 9,340 | -5% | -$153.4K | |
| 2025-03-05 | 2025-03-03 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | A - Grant | $0.00 | +1,403 | 9,802 | +17% | $0 | |
| 2024-11-06 | 2024-11-05 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $316.91 | -212 | 8,383 | -2% | -$67.2K | |
| D | 2024-05-09 | 2024-05-07 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | A - Grant | $0.00 | +532 | 8,559 | +7% | $0 |
| 2024-05-07 | 2024-05-05 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $311.29 | -41 | 8,027 | -0.5% | -$12.8K | |
| 2024-05-06 | 2024-05-02 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $277.37 | -74 | 8,068 | -0.9% | -$20.5K | |
| 2024-05-02 | 2024-04-30 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $276.38 | -48 | 8,142 | -0.6% | -$13.3K | |
| 2024-03-20 | 2024-03-18 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $268.87 | -438 | 8,190 | -5% | -$117.8K | |
| 2024-03-08 | 2024-03-06 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | A - Grant | $0.00 | +1,256 | 8,597 | +17% | $0 | |
| M | 2023-11-07 | 2023-11-05 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $269.86 | -317 | 7,323 | -4% | -$85.5K |
| 2023-05-09 | 2023-05-05 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $231.89 | -39 | 7,581 | -0.5% | -$9,044 | |
| D | 2023-05-04 | 2023-05-03 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $235.97 | -57 | 7,620 | -0.7% | -$13.5K |
| D | 2023-05-04 | 2023-05-02 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | A - Grant | $0.00 | +593 | 7,677 | +8% | $0 |
| 2023-05-02 | 2023-04-30 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $239.74 | -47 | 7,084 | -0.7% | -$11.3K | |
| 2023-03-20 | 2023-03-17 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $234.57 | -241 | 7,103 | -3% | -$56.5K | |
| 2023-03-08 | 2023-03-06 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | A - Grant | $0.00 | +687 | 7,338 | +10% | $0 | |
| 2022-11-10 | 2022-11-09 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | S - Sale | $292.90 | -387 | 6,630 | -6% | -$113.4K | |
| 2022-11-08 | 2022-11-05 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $269.04 | -168 | 7,017 | -2% | -$45.2K | |
| 2022-08-02 | 2022-07-31 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $247.47 | -217 | 7,158 | -3% | -$53.7K | |
| 2022-05-09 | 2022-05-05 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $236.10 | -37 | 7,344 | -0.5% | -$8,736 | |
| D | 2022-05-04 | 2022-05-02 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | A - Grant | $0.00 | +606 | 7,434 | +9% | $0 |
| D | 2022-05-04 | 2022-05-03 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $230.92 | -53 | 7,381 | -0.7% | -$12.2K |
| 2022-04-29 | 2022-04-27 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $249.87 | -28 | 6,828 | -0.4% | -$6,996 | |
| 2022-03-22 | 2022-03-18 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | F - Tax | $235.86 | -322 | 6,856 | -4% | -$75.9K | |
| 2022-03-03 | 2022-03-01 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | A - Grant | $0.00 | +923 | 7,139 | +15% | $0 | |
| M | 2021-11-09 | 2021-11-05 | AMGN | Amgen | Khosla Rachna | SVP, Business Development | A - Grant | $0.00 | +2,104 | 6,185 | +52% | $0 |
Purchase Sale Sale after option exercise All abbreviations